ILMN Illumina, Inc.
Illumina, Inc. (ILMN) is expected to report earnings on October 29, 2026, after the market close. The consensus earnings estimate is $1.38 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -6.1% since its last earnings release on July 30, 2026.
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About Illumina, Inc.
Illumina Inc provides sequencing-and array-based solutions for genetic analysis. Its products enabled researchers to explore DNA, helping them create the first map of gene variations associated with health, disease, and drug response.
Sector
Healthcare
Industry
Medical Instruments/Supply